Is the Androgen Receptor a viable Target in Triple Negative Breast Cancer in 5 Years?
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 813, doi. 10.1016/j.clbc.2023.06.009
- By:
- Publication type:
- Article
Works matching IS 15268209 AND DT 2023 AND VI 23 AND IP 8
Results: 12
1
2
A Review of AI-Based Radiomics and Computational Pathology Approaches in Triple-Negative Breast Cancer: Current Applications and Perspectives.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 800, doi. 10.1016/j.clbc.2023.06.004
- By:
- Publication type:
- Article
3
Metaplastic Breast Cancer: Current: Understanaing and Future Directions.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 775, doi. 10.1016/j.clbc.2023.04.004
- By:
- Publication type:
- Article
4
Triple Negative Breast Cancer and Brain Metastases.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 825, doi. 10.1016/j.clbc.2023.07.008
- By:
- Publication type:
- Article
5
Molecularly Targeted Therapies for Triple Negative Breast Cancer: History, Advances, and Future Directions.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 784, doi. 10.1016/j.clbc.2023.05.012
- By:
- Publication type:
- Article
6
Neoadjuvant Chemotherapy of Taxanes With or Without Anthracyclines in Different Molecular Subtypes of Breast Cancer: A Propensity Score Matching Study.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 882, doi. 10.1016/j.clbc.2023.09.010
- By:
- Publication type:
- Article
7
Factors Influencing Recurrence in Medial Breast Cancer Tumors After Skin Sparing Mastectomy and Immediate Breast Reconstruction.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 876, doi. 10.1016/j.clbc.2023.09.006
- By:
- Publication type:
- Article
8
Prognostic Factors and Survival Outcomes of Patients With Early HER2+ Breast Cancer Treated With Trastuzumab in a Brazilian Public Reference Center: A Real-World Study.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 864, doi. 10.1016/j.clbc.2023.08.009
- By:
- Publication type:
- Article
9
The Effects of High Deductible Health Plans on Breast Cancer Treatment and Reconstruction.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 856, doi. 10.1016/j.clbc.2023.08.006
- By:
- Publication type:
- Article
10
Efficacy and Safety of Trastuzumab Deruxtecan in Breast Cancer: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 847, doi. 10.1016/j.clbc.2023.09.005
- By:
- Publication type:
- Article
11
Safety and Serum Estradiol Levels in Hormonal Treatments for Vulvovaginal Atrophy in Breast Cancer Survivors: A Systematic Review and Meta-Analysis.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 835, doi. 10.1016/j.clbc.2023.08.003
- By:
- Publication type:
- Article
12
Monitoring of Triple Negative Breast Cancer After Neoadjuvant Chemotherapy.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 8, p. 832, doi. 10.1016/j.clbc.2023.08.001
- By:
- Publication type:
- Article